Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine
Retrieved on:
Monday, June 21, 2021
Biotechnology, Pharmaceutical, Health, Clinical trials, Migraine, Headaches, Branches of biology, Nervous system, Medicine, Neurological disorders, Channelopathies, Rare diseases, Migraine-associated vertigo, Messoud Ashina, the Epidemiological Study, the ‘Beyond Migraine: The Real You survey, Teva, THE EPIDEMIOLOGICAL STUDY, THE ‘BEYOND MIGRAINE: THE REAL YOU SURVEY, TEVA
A retrospective study of migraine epidemiology in Southern Israel, supported by Teva and presented at the virtual 7th Congress of the European Academy of Neurology (EAN), found extreme variability in the prevalence of diagnosed patients with migraine across the geographic area studied.
Key Points:
- A retrospective study of migraine epidemiology in Southern Israel, supported by Teva and presented at the virtual 7th Congress of the European Academy of Neurology (EAN), found extreme variability in the prevalence of diagnosed patients with migraine across the geographic area studied.
- Migraine is a difficult, challenging neurological disease which does not discriminate dependent on an individuals social status.
- We believe migraine should be prioritised as a highly prevalent and often under-looked neurological disorder.
- A 2020 Teva-sponsored research project, Beyond Migraine: The Real You, surveyed over 7,500 people living with the disease in 10 European countries.